A Look Back at our 2020 Scholarship Winners – 2021 Applications Now Open
In 2020, NF Midwest awarded $1,000 academic scholarships to six adults affected by neurofibromatosis or schwannomatosis. This is the seventh…
Read MoreIn 2020, NF Midwest awarded $1,000 academic scholarships to six adults affected by neurofibromatosis or schwannomatosis. This is the seventh…
Read MoreIf you’re a post high school student with neurofibromatosis or schwannomatosis, and you live in NF Midwest’s service region of Illinois,…
Read MoreNF Midwest, NF Northeast, and Texas NF are excited to bring two special NF Power Hours to their NF communities. These are…
Read MoreOptic pathway gliomas are benign (low grade) pilocytic tumors. They may involve any location in the optic pathway, starting on…
Read MorePeople who themselves have been diagnosed with NF1, NF2 and Schwannomatosis, or who have a child with one of these…
Read MoreVelopharyngeal insufficiency (VPI) is a resonance disorder that occurs during speech that results from the inability of the vellum (or…
Read MoreDue to the pandemic there will be NO NF Midwest Symposium and iNFo Fair this year. We may present short…
Read MoreKOSELUGO FAQS In April 2020 the U.S. Food and Drug Administration (FDA) approved KOSELUGOTM (selumetinib) for use in children over…
Read MoreWe want you to know that we are working from home to do anything we can to continue to support you…
Read MoreNF Midwest has had a very important article written about Malignant Peripheral Nerve Sheath Tumors (or MPNSTs) in Neurofibromatosis Type…
Read More
© 2024 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.